UroEdge™ Learning Centers

UroEdge™

Imaging

Cancer diagnosis and therapy is becoming more focused toward a patient-specific approach to therapy, particularly prostate cancer. The role of imaging is paramount in this evolution by providing physicians with accurate information on both the presence and extent of prostate cancers. Developments in molecular imaging are paving the way for more physicians to diagnose cancer and apply relevant therapy.

 

UroEdge™

Non-Muscle-Invasive Bladder Cancer (NMIBC)

Non-Muscle-Invasive Bladder Cancer (NMIBC) is a form of bladder cancer confined to the inner lining of the bladder that has not invaded the muscular wall. The Grand Rounds in Urology Learning Center provides expert insights into the diagnosis, risk stratification, treatment, and surveillance of NMIBC, including transurethral resection, intravesical therapies, BCG-unresponsive disease, and emerging treatment options. Explore the latest clinical research, expert discussions, and evidence-based strategies to improve patient outcomes and reduce recurrence and progression.

 

UroEdge™

Theranostics in Prostate Cancer

Theranostics is an evolving approach in urologic oncology that combines targeted molecular imaging with precision radiopharmaceutical therapy to diagnose and treat cancer. The Theranostics Learning Center provides expert insights into PSMA PET imaging, radioligand therapy, patient selection, treatment sequencing, and emerging theranostic technologies. Explore the latest clinical research, expert discussions, and evidence-based strategies shaping personalized prostate cancer care and improving patient outcomes.

 

Functional and Reconstructive Urology

Urologists should be the experts in the management of lower urinary tract disorders. In recent years, other specialties have led the management of patients that are traditionally managed by the urologist. These specialties although improved the care of some women, they failed the general population as the focus was on gender not the disease.